Enlivex Therapeutics Ltd. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enlivex Therapeutics Ltd. annual/quarterly Depreciation history and growth rate from 2012 to 2023.
  • Enlivex Therapeutics Ltd. Depreciation for the quarter ending June 30, 2022 was $176K, a 44.3% increase year-over-year.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2023 was $835K, a 7.47% increase from 2022.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2022 was $777K, a 42.3% increase from 2021.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2021 was $546K, a 90.9% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $835K +$58K +7.47% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-30
2022 $777K +$231K +42.3% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-30
2021 $546K +$260K +90.9% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-30
2020 $286K +$80K +38.8% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-10
2019 $206K +$85K +70.2% Jan 1, 2019 Dec 31, 2019 20-F 2022-04-29
2018 $121K +$38K +45.8% Jan 1, 2018 Dec 31, 2018 20-F 2021-04-30
2017 $83K +$45K +118% Jan 1, 2017 Dec 31, 2017 20-F 2020-04-30
2016 $38K +$21K +124% Jan 1, 2016 Dec 31, 2016 20-F/A 2020-01-23
2015 $17K +$12K +240% Jan 1, 2015 Dec 31, 2015 20-F 2018-04-23
2014 $5K +$5K Jan 1, 2014 Dec 31, 2014 20-F 2017-02-24
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 20-F 2016-03-29
2012 $0 Jan 1, 2012 Dec 31, 2012 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.